DiagnosisResearchImmune and proliferation signatures point in opposite directions in stage I TNBCA retrospective study of 253 patients suggests that immune and proliferative features of the tumour influence prognosis in opposite ways in stage I triple-negative breast cancer....oncomamaEur J CancerOctober 11, 2026
TreatmentWider access to T-DM1 and pertuzumab could avert deaths from HER2+ cancer in BraziloncomamaBreastOctober 11, 2026
DiagnosisSurgery & ReconstructionSupine MRI may reduce positive margins in breast-conserving surgeryoncomamaClin Breast CancerOctober 10, 2026
Breast UnitsTreatmentFive-fraction breast radiotherapy: good tolerability and early tumour controloncomamaClin Breast CancerOctober 10, 2026
DiagnosisNeutrophil-to-lymphocyte ratio may predict pembrolizumab response in TNBConcomamaClin Breast CancerOctober 9, 2026
